📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Investigating the potential impact of PCSK9-inhibitors on mood disorders using eQTL-based Mendelian randomization. (2022)

First Author: Aman A

Attributed to: Understanding the excess risk of cardiometabolic disease in individuals with serious mental illness funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1371/journal.pone.0279381

PubMed Identifier: 36580462

Publication URI: http://europepmc.org/abstract/MED/36580462

Type: Journal Article/Review

Volume: 17

Parent Publication: PloS one

Issue: 12

ISSN: 1932-6203